655389923	655389923	CD	B-NP	O
|	|	NN	I-NP	O
KRCH	KRCH	NN	I-NP	O
|	|	NN	I-NP	O
39395716	39395716	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3287916	3287916	CD	B-NP	O
|	|	CC	I-NP	O
10/16/2005	10/16/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/4/2005	10/4/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/17/2005	8/17/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MACCARONE	MACCARONE	NNP	B-NP	O
,	,	,	O	O
HERB	HERB	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
Na	Na	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
and	and	CC	O	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
59-year-old	59-year-old	JJ	B-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
under	under	IN	B-PP	O
significant	significant	JJ	B-NP	O
stress	stress	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
since	since	IN	B-PP	O
last	last	JJ	B-NP	O
summer	summer	NN	I-NP	O
and	and	CC	I-NP	O
notes	note	NNS	I-NP	O
slowly	slowly	RB	B-VP	O
declining	decline	VBG	I-VP	O
health	health	NN	B-NP	O
since	since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
since	since	IN	B-PP	O
September	September	NNP	B-NP	O
2004	2004	CD	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
gotten	get	VBN	I-VP	O
worse	worse	JJR	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
one	one	CD	I-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
even	even	RB	B-ADJP	O
significantly	significantly	RB	I-ADJP	O
worse	worse	JJR	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
notes	note	NNS	I-NP	O
increasing	increase	VBG	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
side	side	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
side	side	NN	I-NP	O
being	be	VBG	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
girth	girth	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
two-to	two-to	JJ	B-NP	O
three-pillow	three-pillow	JJ	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
from	from	IN	B-PP	O
one-pillow	one-pillow	JJ	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADJP	O
-RRB-	-RRB-	JJ	I-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
increased	increase	VBN	I-NP	O
nocturia	nocturia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
notes	note	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
is	be	VBZ	B-VP	O
``	``	``	O	O
not	not	RB	O	O
angina	angina	NN	B-NP	O
;	;	:	O	O
I	I	PRP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
that	that	DT	B-NP	O
.	.	.	O	O
''	''	''	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
radiation	radiation	NN	B-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
says	say	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
check	check	VB	I-VP	O
her	her	PRP$	B-NP	O
weigh	weigh	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
``	``	``	O	O
knows	know	NNS	B-NP	O
''	''	''	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
failure	failure	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
short	short	JJ	B-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
notes	note	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
some	some	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
stating	state	VBG	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
started	start	VBD	B-VP	O
about	about	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
half	half	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
gone	go	VBN	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Sunday	Sunday	NNP	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reportedly	reportedly	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
benign	benign	JJ	I-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
low-grade	low-grade	JJ	B-NP	O
temperature	temperature	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
recent	recent	JJ	B-NP	O
Levaquin	Levaquin	NNP	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
C.	C.	NNP	I-NP	O
difficile	difficile	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
stopped	stop	VBD	B-VP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
still	still	RB	I-VP	O
remained	remain	VBN	I-VP	O
some	some	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
nonproductive	nonproductive	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
increasing	increase	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
output	output	NN	I-NP	O
per	per	IN	B-PP	O
report	report	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
shortly	shortly	RB	B-ADVP	O
thereafter	thereafter	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
10/10	10/10	CD	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
some	some	DT	B-NP	O
Dilaudid	Dilaudid	NNP	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
interview	interview	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
projectile	projectile	JJ	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
pass	pass	VB	I-VP	O
gas	gas	NN	B-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
reported	report	VBD	B-VP	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
night	night	NN	B-NP	O
sweats	sweat	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reported	report	VBD	B-VP	O
no	no	DT	B-NP	O
bright	bright	JJ	I-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reported	report	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
bowel	bowel	NN	I-NP	O
,	,	,	O	O
bladder	bladder	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
urinary	urinary	JJ	B-NP	O
habits	habit	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Rheumatic	Rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
and	and	CC	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
1981	1981	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
porcine	porcine	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
1991	1991	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
St.	St.	NNP	B-NP	O
Jude	Jude	NNP	I-NP	O
valve	valve	NNP	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
AVR	AVR	NN	B-NP	B-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Endocarditis	Endocarditis	NN	B-NP	O
in	in	IN	B-PP	O
1991	1991	CD	B-NP	O
and	and	CC	O	O
porcine	porcine	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
ankle	ankle	NN	I-NP	O
fracture	fracture	NN	I-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
ORIF	ORIF	NN	I-NP	B-protein
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
ventral	ventral	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
laparoscopic	laparoscopic	JJ	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	IN	B-PP	O
breast	breast	NN	B-NP	O
biopsy	biopsy	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

TIA	TIA	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

Dove	Dove	NNP	B-NP	O
soap	soap	NN	I-NP	O
does	do	VBZ	B-VP	O
give	give	VB	I-VP	O
her	her	PRP$	B-NP	O
hives	hive	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.o.d.	q.o.d.	NN	I-NP	O
alternating	alternate	VBG	B-VP	O
with	with	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
Lasix	Lasix	NNP	I-NP	O
q.o.d.	q.o.d.	FW	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
q.o.d.	q.o.d.	RB	B-VP	O
alternating	alternate	VBG	I-VP	O
with	with	IN	B-PP	O
0.25	0.25	CD	B-NP	O
q.o.d.	q.o.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
6	6	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.o.d.	q.o.d.	NN	I-NP	O
,	,	,	O	O
alternating	alternate	VBG	B-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
mg	mg	NN	I-NP	O
q.o.d.	q.o.d.	IN	B-PP	O
5	5	CD	B-NP	O
.	.	.	O	O

Omeprazole	Omeprazole	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-ADVP	I-protein
6	6	CD	B-NP	I-protein
.	.	.	O	O

Metformin	Metformin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
70/30	70/30	CD	I-NP	I-protein
65	65	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	RB	B-ADVP	O
,	,	,	O	O
35	35	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	B-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	B-protein
600	600	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Magnesium	Magnesium	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Iron	Iron	NN	B-NP	O
tablets	tablet	NNS	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Actonel	Actonel	NNP	B-NP	O
every	every	DT	I-NP	O
Wednesday	Wednesday	NNP	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
quit	quit	VBD	B-VP	O
smoking	smoking	NN	B-NP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
maximum	maximum	NN	I-NP	O
was	be	VBD	B-VP	O
three	three	CD	B-NP	O
to	to	TO	I-NP	O
four	four	CD	I-NP	O
packs	pack	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
35	35	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

As	As	RB	B-ADVP	O
far	far	RB	I-ADVP	O
as	as	IN	B-SBAR	O
her	her	PRP$	B-NP	O
alcohol	alcohol	NN	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
drinks	drink	VBZ	B-VP	O
occasional	occasional	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
any	any	DT	B-NP	O
illicit	illicit	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
used	use	VBD	B-VP	O
to	to	TO	I-VP	O
work	work	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
hairdresser	hairdresser	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
increased	increase	VBN	I-VP	O
stress	stress	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
son	son	NN	I-NP	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
schizophrenia	schizophrenia	NN	B-NP	O
and	and	CC	O	O
another	another	DT	B-NP	O
son	son	NN	I-NP	O
who	who	WP	B-NP	O
abuses	abuse	VBZ	B-VP	O
drugs	drug	NNS	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
violent	violent	JJ	B-NP	O
tendencies	tendency	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
are	be	VBP	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
temperature	temperature	NN	B-NP	O
of	of	IN	B-PP	O
98.7	98.7	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
111/61	111/61	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
30	30	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
vitals	vital	NNS	B-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
arrived	arrive	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
anxious	anxious	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
pleasant	pleasant	NN	B-NP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
left	left	JJ	I-NP	O
eye	eye	NN	I-NP	O
is	be	VBZ	B-VP	O
artificial	artificial	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
eye	eye	NN	I-NP	O
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
3	3	CD	I-NP	O
mm	mm	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
moist	moist	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
erosion	erosion	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
gum	gum	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
erythema	erythema	NN	I-NP	O
or	or	CC	I-NP	O
exudate	exudate	NN	I-NP	O
seen	see	VBN	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
tonsils	tonsil	NNS	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
noted	note	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
approximately	approximately	RB	B-NP	O
6	6	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
is	be	VBZ	B-VP	O
supple	supple	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
full	full	JJ	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Heart	Heart	NNP	B-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
premature	premature	JJ	I-NP	O
beats	beat	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
mechanical	mechanical	JJ	B-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
3/6	3/6	CD	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
additionally	additionally	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
RV	RV	NN	I-NP	O
heave	heave	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
PMI	PMI	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
diffuse	diffuse	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
nondisplaced	nondisplaced	JJ	B-ADJP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
Faint	Faint	NN	B-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
base	base	NN	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
wheezes	wheeze	VBZ	B-VP	O
or	or	CC	O	O
rhonchi	rhonchi	NN	B-NP	O
are	be	VBP	B-VP	O
heard	hear	VBN	I-VP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Slightly	Slightly	JJ	B-NP	O
tympanic	tympanic	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
quadrant	quadrant	NN	I-NP	O
is	be	VBZ	B-VP	O
slightly	slightly	RB	B-ADVP	O
tender	tender	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
active	active	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
liver	liver	NN	I-NP	O
edge	edge	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
palpable	palpable	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
spleen	spleen	NN	I-NP	O
tip	tip	NN	I-NP	O
is	be	VBZ	B-VP	O
nonpalpable	nonpalpable	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
1	1	CD	I-NP	O
+	+	SYM	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
slightly	slightly	RB	B-ADJP	O
pitting	pitting	JJ	I-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
126	126	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.4	4.4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
93	93	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
24	24	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
28	28	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.4	1.4	CD	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
and	and	CC	I-NP	O
1.3	1.3	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
160	160	CD	I-NP	O
.	.	.	O	O

CBC	CBC	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
9.9	9.9	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
27.9	27.9	CD	I-NP	I-protein
,	,	,	O	O
platelet	platelet	NN	B-NP	B-protein
count	count	NN	I-NP	I-protein
274	274	CD	I-NP	I-protein
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
are	be	VBP	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
ALT	ALT	NN	B-NP	B-protein
56	56	CD	I-NP	I-protein
,	,	,	O	O
AST	AST	NN	B-NP	O
83	83	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
52	52	CD	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.1	0.1	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
4.2	4.2	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
total	total	JJ	B-NP	O
protein	protein	NN	I-NP	O
7.4	7.4	CD	I-NP	O
.	.	.	O	O

STUDIES	STUDIES	NNS	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
junctional	junctional	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
65	65	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
frequent	frequent	JJ	B-NP	O
PVCs	PVC	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
access	access	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
some	some	DT	B-NP	O
nonspecific	nonspecific	JJ	I-NP	O
T-wave	T-wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
X-RAY	X-RAY	NN	I-NP	O
:	:	:	O	O
Showed	Show	VBD	B-VP	O
mild	mild	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
59-year-old	59-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rheumatic	rheumatic	JJ	I-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
St.	St.	NNP	I-NP	I-protein
Jude	Jude	NNP	I-NP	I-protein
's	's	POS	B-NP	I-protein
MVR	MVR	NN	I-NP	I-protein
and	and	CC	I-NP	O
AVR	AVR	NN	I-NP	B-protein
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
and	and	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NNP	B-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
a.	a.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
troponins	troponin	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
mild	mild	JJ	B-NP	O
demand	demand	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
slight	slight	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
contributed	contribute	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
demand	demand	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
clear	clear	JJ	I-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
fine	fine	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
EKGs	EKG	NNS	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
laid	lay	VBD	B-VP	O
her	her	PRP$	B-NP	O
head	head	NN	I-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
future	future	JJ	B-NP	O
AVR	AVR	NN	I-NP	O
and	and	CC	I-NP	O
MVR	MVR	NN	I-NP	B-protein
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Surgical	Surgical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bio	Bio	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
workup	workup	NN	I-NP	O
was	be	VBD	B-VP	O
extensive	extensive	JJ	B-ADJP	O
and	and	CC	O	O
included	include	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hemodynamics	hemodynamic	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
RA	RA	NN	B-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
,	,	,	O	O
PA	PA	NN	B-NP	O
of	of	IN	B-PP	O
92/23/44	92/23/44	CD	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
22	22	CD	B-NP	O
with	with	IN	B-PP	O
V	V	NN	B-NP	O
waves	wave	NNS	I-NP	O
to	to	TO	B-PP	O
42	42	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
was	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
normal	normal	JJ	I-ADJP	O
with	with	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
leaflet	leaflet	NN	I-NP	O
motion	motion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
AV	AV	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
grossly	grossly	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
overall	overall	JJ	I-NP	O
conclusion	conclusion	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
right-sided	right-sided	JJ	B-NP	O
heart	heart	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
major	major	JJ	B-NP	O
atherosclerotic	atherosclerotic	JJ	I-NP	O
disease	disease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
.	.	.	O	O

b.	b.	RB	B-ADVP	O
Pump	Pump	NNP	B-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
see	see	VB	B-VP	O
cath	cath	NN	B-NP	O
report	report	NN	I-NP	O
as	as	IN	B-PP	O
above	above	RB	I-PP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
diuresed	diurese	VBN	B-VP	O
with	with	IN	B-PP	O
IV	IV	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
came	come	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
euvolemic	euvolemic	JJ	I-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
with	with	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
b.i.d.	b.i.d.	JJ	I-NP	O
basis	basis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
until	until	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
bump	bump	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
to	to	TO	B-PP	O
1.8	1.8	CD	B-NP	O
,	,	,	I-NP	O
1.9	1.9	CD	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
diuresis	diuresis	NN	B-NP	O
was	be	VBD	B-VP	O
slowly	slowly	RB	I-VP	O
modified	modify	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
placed	place	VBN	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
Lasix	Lasix	NNP	I-NP	O
q.o.d.	q.o.d.	NNP	I-NP	O
.	.	.	O	O

That	That	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
dosing	dosing	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
on	on	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
.	.	.	O	O

c.	c.	NN	B-NP	O
Rhythm	Rhythm	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
rate	rate	NN	B-NP	O
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
digoxin	digoxin	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
EP	EP	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
epicardial	epicardial	JJ	B-NP	O
lead	lead	NN	I-NP	O
placement	placement	NN	I-NP	O
at	at	IN	B-PP	O
surgery	surgery	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
tachybrady	tachybrady	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
diltiazem	diltiazem	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
modified	modify	VBD	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
her	her	PRP$	B-NP	O
valvular	valvular	JJ	I-NP	O
repair	repair	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
very	very	RB	I-NP	O
near	near	JJ	I-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

d.	d.	LS	B-NP	O
Presurgical	Presurgical	JJ	I-NP	O
workup	workup	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-VP	O
echo	echo	VB	I-VP	O
,	,	,	O	O
right	right	JJ	B-ADVP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
heart	heart	NN	B-NP	O
cath	cath	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
TEE	TEE	NN	I-NP	O
performed	perform	VBN	B-VP	O
.	.	.	O	O

TEE	TEE	NN	B-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
left	left	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
appendage	appendage	NN	I-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
localized	localize	VBN	B-NP	O
thrombus	thrombus	NN	I-NP	O
.	.	.	O	O

St.	St.	NNP	B-NP	O
Jude	Jude	NNP	I-NP	O
's	's	POS	B-NP	O
valve	valve	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
seated	seat	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
position	position	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
aortic	aortic	JJ	I-NP	O
regurg	regurg	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
St.	St.	NNP	I-NP	O
Jude	Jude	NNP	I-NP	O
's	's	POS	B-NP	O
valve	valve	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
seated	seat	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
position	position	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
trace	trace	NN	B-NP	O
mild	mild	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
slight	slight	JJ	B-NP	O
asynchronous	asynchronous	JJ	I-NP	O
motion	motion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prosthetic	prosthetic	JJ	I-NP	O
valve	valve	NN	I-NP	O
apparatus	apparatus	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
valve	valve	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
in	in	IN	B-PP	O
appearance	appearance	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
mild	mild	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Visualized	Visualize	VBN	B-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
thoracic	thoracic	JJ	I-NP	O
aorta	aorta	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
minimal	minimal	JJ	B-NP	O
atheromatous	atheromatous	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
sat	sat	VB	I-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
required	require	VBN	I-VP	O
any	any	DT	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
KUB	KUB	NN	I-NP	B-protein
performed	perform	VBN	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
potential	potential	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
single	single	JJ	I-NP	O
frontal	frontal	JJ	I-NP	O
view	view	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
reported	report	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
final	final	JJ	I-NP	O
radiology	radiology	NN	I-NP	O
report	report	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
gas	gas	NN	B-NP	B-DNA
seen	see	VBN	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
loops	loop	NNS	I-NP	O
of	of	IN	B-PP	O
small	small	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
colon	colon	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
bowel	bowel	NN	I-NP	O
dilatation	dilatation	NN	I-NP	O
seen	see	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
overall	overall	JJ	I-NP	O
impression	impression	NN	I-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
high-grade	high-grade	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hepatic	hepatic	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	O	O
vomiting	vomit	VBG	B-VP	O
eventually	eventually	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
and	and	CC	O	O
perhaps	perhaps	RB	B-ADVP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
some	some	DT	B-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
viral	viral	JJ	B-NP	O
illness	illness	NN	I-NP	O
or	or	CC	I-NP	O
gastroenteritis	gastroenteritis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
cramping	cramping	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
PPI	PPI	NN	I-NP	B-protein
for	for	IN	B-PP	O
GERD	GERD	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
one	one	CD	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
required	require	VBD	B-VP	O
increasing	increase	VBG	I-VP	O
her	her	PRP$	B-NP	O
dosage	dosage	NN	I-NP	O
of	of	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
GERD-like	GERD-like	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
seemed	seem	VBD	B-VP	O
that	that	IN	B-SBAR	O
increasing	increase	VBG	B-VP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
,	,	,	O	O
precipitated	precipitate	VBD	B-VP	O
some	some	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
returned	return	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
dosing	dosing	NN	I-NP	O
of	of	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
while	while	IN	B-SBAR	O
in-house	in-house	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
omeprazole	omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
prescription	prescription	NN	B-NP	O
for	for	IN	B-PP	O
Colace	Colace	NNP	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
Senokot	Senokot	NN	B-NP	O
today	today	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
using	use	VBG	I-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
remained	remain	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
with	with	IN	B-PP	O
averaging	average	VBG	B-NP	O
of	of	IN	B-PP	O
26	26	CD	B-NP	O
to	to	TO	B-PP	O
27	27	CD	B-NP	O
as	as	RB	B-ADVP	O
far	far	RB	I-ADVP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
concerned	concern	VBN	I-VP	O
with	with	IN	B-PP	O
keeping	keep	VBG	B-VP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
30	30	CD	B-NP	O
or	or	CC	I-NP	O
above	above	RB	I-NP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
times	time	NNS	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
clean	clean	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
seen	see	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
and	and	CC	I-NP	O
also	also	RB	I-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
dip	dip	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
at	at	IN	B-PP	O
one	one	CD	B-NP	O
point	point	NN	I-NP	O
requiring	require	VBG	B-VP	O
two	two	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
bumped	bump	VBD	B-VP	O
appropriately	appropriately	RB	B-ADVP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
or	or	CC	I-NP	O
31	31	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
required	require	VBD	B-VP	O
no	no	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
transfusions	transfusion	NNS	I-NP	O
thereafter	thereafter	RB	B-ADVP	O
.	.	.	O	O

With	With	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
heparin	heparin	NN	I-NP	O
drip	drip	NN	I-NP	O
at	at	IN	B-PP	O
950	950	CD	B-NP	B-DNA
units	unit	NNS	I-NP	I-DNA
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
a	a	DT	B-NP	O
PTT	PTT	NN	I-NP	O
between	between	IN	B-PP	O
60	60	CD	B-NP	O
and	and	CC	I-NP	O
80	80	CD	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
mechanical	mechanical	JJ	I-NP	O
valves	valve	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
this	this	DT	B-NP	O
Lovenox	Lovenox	NNP	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
and	and	CC	O	O
stop	stop	VB	B-VP	O
it	it	PRP	B-NP	O
one	one	CD	B-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
surgery	surgery	NN	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
home	home	NN	B-NP	O
VNA	VNA	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
did	do	VBD	B-VP	O
elevate	elevate	VB	I-VP	O
to	to	TO	B-PP	O
as	as	RB	B-ADVP	O
high	high	JJ	I-ADVP	O
as	as	IN	B-PP	O
3.3	3.3	CD	B-NP	O
,	,	,	O	O
3.4	3.4	CD	B-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
ongoing	ongoing	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
diuresis	diuresis	NN	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
given	give	VBN	B-PP	O
her	her	PRP	B-NP	O
markedly	markedly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
and	and	CC	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
more	more	RBR	B-ADJP	O
hydrated	hydrated	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
euvolemic	euvolemic	JJ	I-ADJP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
,	,	,	I-NP	O
1.3	1.3	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
now	now	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
We	We	PRP	B-NP	O
appreciated	appreciate	VBD	B-VP	O
the	the	DT	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
following	follow	VBG	B-PP	O
her	her	PRP	B-NP	O
very	very	RB	B-ADVP	O
closely	closely	RB	I-ADVP	O
while	while	IN	B-SBAR	O
in-house	in-house	NN	B-NP	O
.	.	.	O	O

Several	Several	JJ	B-NP	O
modifications	modification	NNS	I-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
while	while	IN	B-SBAR	O
here	here	RB	B-ADVP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
good	good	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
60	60	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
30	30	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
NovoLog	NovoLog	NN	B-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
with	with	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
15	15	CD	B-NP	O
at	at	IN	B-PP	O
dinner	dinner	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
receiving	receive	VBG	I-VP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NovoLog	NovoLog	NNP	I-NP	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
lunch	lunch	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
in	in	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
prescriptions	prescription	NNS	I-NP	O
were	be	VBD	B-VP	O
provided	provide	VBN	I-VP	O
by	by	IN	B-PP	O
Carl	Carl	NNP	B-NP	O
Mcclenahan	Mcclenahan	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
following	follow	VBG	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
will	will	MD	B-VP	O
become	become	VB	I-VP	O
again	again	RB	B-ADJP	O
involved	involve	VBN	I-ADJP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
care	care	NN	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
plans	plan	VBZ	B-VP	O
for	for	IN	B-PP	O
surgery	surgery	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
very	very	RB	I-NP	O
near	near	JJ	I-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
ID	ID	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
entire	entire	JJ	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
upwards	upward	VBZ	B-VP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
20	20	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
planned	plan	VBN	I-NP	O
surgery	surgery	NN	I-NP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Villata	Villata	NNP	I-NP	O
to	to	TO	B-VP	O
repair	repair	VB	I-VP	O
her	her	PRP$	B-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
her	her	PRP$	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
surgery	surgery	NN	I-NP	O
was	be	VBD	B-VP	O
delayed	delay	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
so	so	IN	O	O
an	an	DT	B-NP	O
infectious	infectious	JJ	I-NP	O
workup	workup	NN	I-NP	O
could	could	MD	B-VP	O
ensue	ensue	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
urine	urine	NN	I-NP	O
sent	send	VBD	B-VP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
suggestion	suggestion	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Levaquin	Levaquin	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
.	.	.	O	O

Surveillance	Surveillance	NN	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
groin	groin	NN	I-NP	O
hematoma	hematoma	NN	I-NP	O
that	that	WDT	B-NP	O
performed	perform	VBD	B-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
we	we	PRP	B-NP	O
questioned	question	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
or	or	CC	O	O
not	not	RB	O	O
this	this	DT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
some	some	DT	B-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
infectious	infectious	JJ	B-NP	O
source	source	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
aspirated	aspirate	VBD	B-VP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
identified	identify	VBN	I-NP	O
places	place	NNS	I-NP	O
as	as	RB	B-ADVP	O
far	far	RB	I-ADVP	O
as	as	IN	B-PP	O
source	source	NN	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
believed	believe	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
could	could	MD	B-VP	O
potential	potential	JJ	I-VP	O
have	have	VB	I-VP	O
endocarditis	endocarditis	NN	B-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
actually	actually	RB	B-ADVP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
a	a	DT	B-NP	O
species	species	NN	I-NP	O
of	of	IN	B-PP	O
Abiotrophia	Abiotrophia	NNP	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
culture	culture	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
cultures	culture	NNS	I-NP	O
growing	grow	VBG	B-VP	O
out	out	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
appreciate	appreciate	VBP	B-VP	O
the	the	DT	B-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
Team	Team	NN	I-NP	O
following	follow	VBG	B-PP	O
.	.	.	O	O

Their	Their	PRP$	B-NP	O
recommendations	recommendation	NNS	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
hold	hold	VB	I-VP	O
antibiotics	antibiotic	NNS	B-NP	O
unless	unless	IN	B-SBAR	O
subsequent	subsequent	JJ	B-NP	O
cultures	culture	NNS	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
grow	grow	VB	I-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

Their	Their	PRP$	B-NP	O
recommendations	recommendation	NNS	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
all	all	DT	B-NP	O
cultures	culture	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
perform	perform	VB	I-VP	O
a	a	DT	B-NP	O
TEE	TEE	NN	I-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
TEE	TEE	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
or	or	CC	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
bowel	bowel	NN	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
clearly	clearly	RB	B-ADVP	O
no	no	DT	B-NP	O
vegetation	vegetation	NN	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
either	either	CC	O	O
any	any	DT	B-NP	O
transthoracic	transthoracic	JJ	I-NP	O
echos	echo	NNS	I-NP	O
or	or	CC	I-NP	O
TEEs	TEE	NNS	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
made	make	VBD	B-VP	O
recommendations	recommendation	NNS	B-NP	O
as	as	RB	B-ADJP	O
far	far	RB	I-ADJP	O
as	as	IN	B-SBAR	O
perioperative	perioperative	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
would	would	MD	B-VP	O
include	include	VB	I-VP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
IV	IV	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
assumption	assumption	NN	I-NP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
completing	complete	VBG	I-VP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
therapy	therapy	NN	I-NP	O
after	after	IN	B-PP	O
SBE	SBE	NN	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
would	would	MD	B-VP	O
also	also	RB	I-VP	O
recommend	recommend	VB	I-VP	O
sending	send	VBG	I-VP	O
all	all	DT	B-NP	O
valve	valve	VBP	B-VP	O
tissue	tissue	NN	B-NP	O
for	for	IN	B-PP	O
Gram	Gram	NN	B-NP	B-protein
stain	stain	NN	I-NP	I-protein
and	and	CC	I-NP	O
culture	culture	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
pathology	pathology	NN	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
the	the	DT	B-NP	O
Gram	Gram	NN	I-NP	O
stain	stain	NN	I-NP	O
and	and	CC	I-NP	O
culture	culture	NN	I-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
they	they	PRP	B-NP	O
would	would	MD	B-VP	O
suggest	suggest	VB	I-VP	O
extending	extend	VBG	I-VP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
above-mentioned	above-mentioned	JJ	I-NP	O
antibiotic	antibiotic	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Darvon	Darvon	NNP	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
codeine	codeine	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
groin	groin	NN	I-NP	O
pain	pain	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
much	much	RB	I-VP	O
improved	improve	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
easily	easily	RB	B-ADVP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
Tl	Tl	NNP	I-NP	O
Brown	Brown	NNP	I-NP	O
Vo	Vo	NNP	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
is	be	VBZ	B-VP	O
resolving	resolve	VBG	I-VP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
resolving	resolve	VBG	I-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nutrition	nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
tolerating	tolerate	VBG	I-VP	O
p.o.	p.o.	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
repleted	replete	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Psychologic	Psychologic	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
social	social	JJ	B-NP	O
work	work	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
many	many	JJ	B-NP	O
anxieties	anxiety	NNS	I-NP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
surgery	surgery	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
in	in	IN	B-PP	O
going	go	VBG	B-VP	O
home	home	NN	B-ADVP	O
and	and	CC	O	O
returning	return	VBG	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
social	social	JJ	I-NP	O
environment	environment	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
necessitated	necessitate	VBD	B-VP	O
volume	volume	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
many	many	JJ	B-NP	O
procedures	procedure	NNS	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
severe	severe	JJ	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Disposition	Disposition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
medical	medical	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
with	with	IN	B-PP	O
all	all	DT	B-NP	O
cultures	culture	NNS	I-NP	O
clear	clear	JJ	B-ADJP	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
awaiting	await	VBG	I-VP	O
surgical	surgical	JJ	B-NP	O
repair	repair	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
valve	valve	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
surgery	surgery	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Berreth	Berreth	NNP	I-NP	O
office	office	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Diltiazem	Diltiazem	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.	q.	FW	I-ADVP	O
other	other	JJ	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
60	60	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
30	30	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Senokot	Senokot	NNP	B-NP	O
three	three	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	B-protein
one	one	CD	I-NP	I-protein
tablet	tablet	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Lovenox	Lovenox	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
b.i.d.	b.i.d.	RB	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Caltrate	Caltrate	NN	B-NP	O
plus	plus	CC	O	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
600	600	CD	B-NP	O
mg	mg	NN	I-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	O	O
h.s.	h.s.	NN	B-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

NovoLog	NovoLog	NNP	B-NP	O
15	15	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
with	with	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	I-NP	O
dinner	dinner	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
give	give	VB	I-VP	O
at	at	IN	B-PP	O
lunch	lunch	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Maalox	Maalox	NNP	B-NP	O
tablets	tablet	VBZ	B-VP	O
quick	quick	JJ	B-NP	O
dissolve	dissolve	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Codeine	Codeine	NN	B-NP	O
15	15	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Magnesium	Magnesium	NN	B-NP	O
oxide	oxide	NN	I-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Omeprazole	Omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
PLANS	PLANS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Mccutchan	Mccutchan	NNP	I-NP	O
office	office	NN	I-NP	O
to	to	TO	B-VP	O
coordinate	coordinate	VB	I-VP	O
her	her	PRP$	B-NP	O
appointment	appointment	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
pending	pende	VBG	B-VP	O
her	her	PRP$	B-NP	O
surgeon	surgeon	NN	I-NP	O
's	's	POS	B-NP	O
return	return	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
instructed	instruct	VBN	B-VP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Doug	Doug	NNP	I-NP	O
Schlanger	Schlanger	NNP	I-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
discuss	discuss	VB	I-VP	O
surgical	surgical	JJ	B-NP	O
plans	plan	NNS	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
all	all	DT	B-NP	O
her	her	PRP$	I-NP	B-cell_line
blood	blood	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
followed	follow	VBD	B-VP	O
up	up	RP	B-PRT	O
prior	prior	JJ	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
become	become	VBP	B-VP	O
positive	positive	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
interim	interim	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
will	will	MD	B-VP	O
begin	begin	VB	I-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	I-NP	O
delay	delay	NN	I-NP	O
surgery	surgery	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
discussion	discussion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-7591465	0-7591465	CD	B-NP	O
IS	IS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
CURLESS	CURLESS	NNP	B-NP	O
,	,	,	O	O
OLIVER	OLIVER	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HERD	HERD	NNP	B-NP	O
,	,	,	O	O
ANDREAS	ANDREAS	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8798183	8798183	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/4/05	10/4/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/16/05	7/16/05	CD	B-NP	O

